Document is current

Any future updates will be listed below

Body composition changes and clinical outcomes in pediatric cystic fibrosis during 24 months of lumacaftor ivacaftor therapy based on real-world data

Crossref DOI link: https://doi.org/10.1038/s41598-025-86010-1

Published Online: 2025-01-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark